The National Diabetes Audit (NDA) is part of the National Clinical Audit Programme, which is commissioned by NHS England. The NDA was established in 2004 and measures the quality of diabetes care against NICE recommended standards. The NDA allows policymakers to understand the prevalence of diabetes and measure the standard of care against current policies, including the NHS Five Year Forward Plan. The NDA allows local services to benchmark the care that they are giving and allow them to identify areas for improvement. The NDA is also used in a number of other cardiovascular risk tools such as the Diabetes versus Expenditure Tool and Rightcare Atlas of Variation. The NDA provides key indicators for the CCG Improvement and Assessment Framework, and is the measurement tool that will be used for the Sustainability and Transformation Fund in relation to improvements in diabetes care. The NDA is the only source of diabetes information that offers patient level analysis and the ability to track changes over time.
The ability to offer the NDA as part of the GP contract and via GPES should ensure maximum participation rates whilst easing the burden of data collection on services. The development of a GPES extract will also allow more frequent collection (quarterly), providing more up to date information throughout the audit period to services to guide quality improvement, and more timely reporting.
This service is on CQRS to record a GPs agreement for data extracts to take place only. No data from this service will be recorded in CQRS and there is no payment attached to this service.